1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 795 F.Supp.2d
  5. 795 F.Supp.2d 300 (2011)
 

IN RE FLONASE ANTITRUST LITIGATION

Civil Action Nos. 08-3149, 08-3301, 09-1638.

795 F.Supp.2d 300 (2011)

In re FLONASE ANTITRUST LITIGATION. This Document Relates to: All Actions Roxane Laboratories, Inc., Plaintiff, v. Smithkline Beecham Corporation d/b/a GlaxoSmithKline, Defendant.

United States District Court, E.D. Pennsylvania.

June 2, 2011.

Attorney(s) appearing for the Case

Bruce L. Simon, Jonathan M. Watkins, Pearson, Simon, Warshaw & Penny, LLP, San Francisco, CA, Clifford H. Pearson, Pearson, Simon, Warshaw, Penny, LLP, Sherman Oaks, CA, Steven A. Asher, Mindee J. Reuben, Weinstein, Kitchenoff & Asher, LLC, Philadelphia, PA, for Plaintiff.

Leslie E. John, Stephen J. Kastenberg, Arthur Makadon, Jason A. Leckerman, Jessica Moltisanti Anthony, Susanna R. Greenberg, Ballard, Spahr, Andrews & Ingersoll, LLP, Philadelphia, PA, for Defendant.

MEMORANDUM

ANITA B. BRODY, District Judge.

Flonase is a steroid nasal spray containing the active pharmaceutical ingredient fluticasone propionate ("FP") produced by Defendant SmithKline Beecham Corporation, doing business as GlaxoSmithKline PLC ("GSK").1 Until recently, Flonase was one of the nation's top-selling drugs. Three different suits have been filed against GSK, alleging various antitrust violations stemming from...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases